Pain Detecting and Analgesic Stimulating Device on Low Back Pain
CompletedNot applicableNCT02256410
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Purpose of study is to test in a randomized controlled trial (RCT) the effects of the Nervomatrix device on various clinical outcomes of patients with low back pain, as well as its mechanisms of action.
Study details
- Official title
- The Effects of a Pain Detecting and Analgesic Stimulating Device on Low Back Pain Patients' Clinical Outcomes
- Conditions
- Interventions
- Device: Stimulation
- Other: Sham
- Sponsor
- Vrije Universiteit Brussel
- Start date
- 2013-12
- Primary completion
- 2014-12
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronic low back pain persisting for at least 3 months Exclusion Criteria: * patho-anatomical diagnosis (such as fractures, tumors, rheumatic diseases and neurological diseases) * initiated a new conventional therapy during the study period * pregnant * patients having a cardiac pacemaker, implanted defibrillator, or other implanted metallic or electronic device
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02256410